azathioprine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braquet, P; Foegh, ML; Khirabadi, BS; Ramwell, PW; Rowles, JR | 2 |
2 other study(ies) available for azathioprine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor.
Topics: Animals; Azathioprine; Cyclosporins; Diterpenes; Ginkgolides; Graft Rejection; Graft Survival; Heart Transplantation; Immunity, Cellular; Lactones; Plant Extracts; Platelet Activating Factor; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors; Transplantation, Homologous | 1986 |
The causal role of PAF and leukotrienes in acute cardiac allograft rejection in rats.
Topics: Animals; Azathioprine; Graft Rejection; Heart Transplantation; Platelet Activating Factor; Rats; SRS-A | 1986 |